4-(2-(11-(2-(((2R,3R,4S,5S,6S)-6-CARBOXY-3,4,5-TRIHYDROXYTETRAHYDRO-2H-PYRAN-2-YL)OXY)ETHYL)-5-METHYL-6-OXO-6,11-DIHYDRO-5H-DIPYRIDO(3,2-B:2',3'-E)(1,4)DIAZEPIN-8-YL)ETHOXY)QUINOLINE 1-OXIDE
UNII T7VD4C7353
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(2-(11-(2-(((2r,3r,4s,5s,6s)-6-carboxy-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)oxy)ethyl)-5-methyl-6-oxo-6,11-dihydro-5h-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-8-yl)ethoxy)quinoline 1-oxide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T7VD4C7353.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C31H31N5O10 PGQLKPHOIFYUJV-UDMYXELHSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(2-(11-(2-(((2r,3r,4s,5s,6s)-6-carboxy-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)oxy)ethyl)-5-methyl-6-oxo-6,11-dihydro-5h-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-8-yl)ethoxy)quinoline 1-oxide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.